The widespread adoption of cross-sectional abdominal imaging—such as multiphasic CT scans and contrast-enhanced MRIs—has led to a dramatic rise in the incidental diagnosis of small and moderately sized renal masses. For decades, the reflexive oncologic standard was radical nephrectomy: the complete surgical excision of the diseased kidney along with its surrounding Gerota’s fascia.
However, multi-center registry data has demonstrated that removing an entire kidney often exchanges cancer control for a heightened long-term risk of chronic kidney disease (CKD), hypertension, and cardiovascular events. Today, Robotic Partial Nephrectomy (RPN), or nephron-sparing surgery, serves as the definitive standard of care for resectable renal masses.
While simple, outward-growing (exophytic) tumors are routinely addressed, managing complex renal tumors—those buried deep inside the parenchyma (endophytic), located centrally adjacent to major blood vessels (hilar), or spanning multiple calyces—demands specialized surgical skill.
Practicing at Miami Robotic Surgery within the Comprehensive Urologic Surgery Institute in South Florida, Dr. Shirin Razdan brings fellowship training in robotic surgery and urologic oncology from the Icahn School of Medicine at Mount Sinai in New York. Utilizing both the standard multi-port da Vinci platform and advanced Single Port (SP) techniques, Dr. Razdan performs precise tumor resections for anatomically challenging tumors, prioritizing both cancer clearance and the preservation of long-term kidney function.
The Nephron-Sparing Imperative: Why Parenchymal Volume Matters
Each kidney contains roughly one million microscopic functional units called nephrons. When healthy nephrons are excised, they do not regenerate.
[SOLID RENAL MASS: cT1a / cT1b / Selected cT2]
│
├─► Radical Nephrectomy ──► ~50% immediate reduction in global nephron mass
│ └──► Elevated lifetime risk of de novo CKD & CV events
│
└─► Partial Nephrectomy ──► Targeted excision of tumor + preservation of cortex
└──► Preserves baseline eGFR & long-term vascular health
Preserving functional vascularized renal parenchyma provides essential clinical benefits:
- Preserving Glomerular Filtration Rate (eGFR): Sparing nephrons minimizes the likelihood of developing new-onset renal impairment or pushing pre-existing mild CKD toward end-stage renal disease (ESRD) requiring hemodialysis.
- Cardiovascular Protection: Research has repeatedly demonstrated that even mild postoperative renal impairment independently elevates the risk of cardiac events, strokes, and all-cause mortality. Maintaining two functional kidneys serves as a buffer against future cardiovascular decline.
- Oncologic Equivalence: Clinical trials have confirmed that partial nephrectomy matches the 5- and 10-year oncologic cure rates of radical nephrectomy for tumors up to 7 cm (and in selected cases, beyond).

Navigating Anatomical Complexity: The R.E.N.A.L. Nephrometry Framework
To quantify surgical difficulty and tailor the robotic resection strategy, Dr. Razdan evaluates each mass using standardized scoring systems such as the R.E.N.A.L. Nephrometry Score:
R ──► (R)adius: Maximum tumor diameter in centimeters (≤4 cm, 4–7 cm, >7 cm)
E ──► (E)xophytic / Endophytic: Extent to which mass protrudes vs. burrows into parenchyma
N ──► (N)earness: Distance from deepest tumor edge to the renal collecting system/sinus
A ──► (A)nterior / Posterior: Orientation on the ventral or dorsal surface of the kidney
L ──► (L)ocation: Relationship to polar lines (upper, middle, lower pole)
[Low Complexity: Score 4–6] ──► Superficial, exophytic polar mass
[Moderate Complexity: Score 7–9] ──► Partial endophytic, near mid-kidney
[High Complexity: Score 10–12] ──► Completely endophytic, touching renal sinus or hilar vessels
High-complexity tumors that would have historically triggered a radical nephrectomy—such as endophytic lesions completely surrounded by normal cortex or central masses abutting the main renal artery and vein—can be safely addressed through high-definition 3D visualization, wristed articulation, and intraoperative ultrasonography.
Advanced Surgical Execution: The Robotic Nephron-Sparing Protocol
Excising a deep or central renal tumor while preserving viable nephrons requires an integrated, multi-step operative strategy:
[Targeted Hilum Dissection] ──► Drop-in Robotic Ultrasound ──► Super-Selective / Zero-Ischemia Clamping
│
▼
[Two-Layer Watertight Renorrhaphy] ◄── Negative Margins ◄── [Enucleoresection along Pseudocapsule]
- Precision Hilum Isolation: The main renal artery, its secondary segmental branches, and the renal vein are dissected. Dr. Razdan frequently utilizes super-selective micro-clamping—clamping only the specific segmental arterial branch feeding the tumor while keeping the remaining healthy kidney tissue continuously perfused with blood.
- Real-Time Drop-in Robotic Ultrasound: For endophytic tumors that cannot be visualized on the kidney surface, a flexible robotic ultrasound probe is introduced through a port. This maps tumor depth, identifies the exact distance to the renal collecting system, and outlines underlying blood vessels.
- Tumor Enucleoresection: Using wristed micro-shears with 7 degrees of freedom, the tumor is dissected along its natural fibrous pseudocapsule. This microscopic plane preserves the maximum rim of surrounding healthy nephrons while ensuring clear oncologic margins.
- Targeting Minimal Warm Ischemia Time (WIT): When arterial clamping is necessary, the procedure is executed efficiently to keep the ischemic window strictly below 20 to 25 minutes, preventing ischemic tubular injury.
- Two-Layer Renorrhaphy:
- Inner Layer: Deep medullary bleeding vessels and entered calyces of the collecting system are oversewn with running absorbable sutures to prevent urinary leakage and pseudoaneurysm formation.
- Outer Layer: The cortical defect is re-approximated using sliding-clip renorrhaphy techniques, securing hemostasis and closing the parenchymal defect.
Comparative Overview: Partial Nephrectomy vs. Radical Nephrectomy
| Surgical Metric | Radical Nephrectomy | Robotic Partial Nephrectomy (RPN) |
| Surgical Intent | Complete removal of entire kidney | Precise tumor excision; spare functional kidney |
| Parenchymal Conservation | 0% (entire kidney lost) | 85% to 95%+ viable cortex preserved |
| Warm Ischemia Time | Not applicable | Targeted < 20–25 minutes or zero-ischemia |
| Risk of New-Onset CKD | Substantially higher baseline risk | Significantly lower long-term risk profile |
| Incisions & Invasiveness | Flank incision or multi-port access | Multi-port or single 2.5 cm port (da Vinci SP) |
| Hospital Stay & Recovery | 2 to 4 days inpatient | 1 to 2 days (often outpatient / same-day SP discharge) |
| Cancer Control Efficacy | 95%+ local control | Equivalent 95%+ local recurrence-free survival |
Conclusion
A diagnosis of a solid renal mass—even one categorized as anatomically complex, central, or deeply embedded—does not mean you must forfeit your entire kidney. Through robotic partial nephrectomy, intraoperative ultrasound mapping, and nephron-sparing micro-reconstruction, Dr. Shirin Razdan delivers cancer control while safeguarding long-term renal function and overall health.
- Surgeon: Dr. Shirin Razdan, MD
- Specialty: Fellowship-Trained Robotic Urologic Surgeon & Urologic Oncologist
- Practice: Miami Robotic Surgery / Comprehensive Urologic Surgery Institute
- Office Location: 3650 NW 82nd Avenue, Suite 502, Doral/Miami, FL 33166
- Official Practice Website:miamiroboticsurgery.com
- Direct Consultations & Appointments: (305) 468-3314